Fig. 12From: De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learningChemical space of predicted hits (yellow) and Mpro inhibitors of SARS-CoV-1 (indigo) and SARS-CoV-2 (light green)Back to article page